Perspective Therapeutics (CATX) Net Margin Growth (5y) (2015 - 2023)
Perspective Therapeutics (CATX) Net Margin Growth (5y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 126.77 Bn | 123.30 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.05 Bn | 47.80 Bn | 1.35 Bn |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 388.50 Mn | 388.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 18,010.00 |
| Sep 30, 2023 | 6,085.00 |
| Jun 30, 2023 | 3,929.00 |
| Mar 31, 2023 | 1,381.00 |
| Sep 30, 2022 | 2,285.00 |
| Jun 30, 2022 | 9,725.00 |
| Mar 31, 2022 | 6,003.00 |
| Dec 31, 2021 | 8,428.00 |
| Sep 30, 2021 | 5,137.00 |
| Jun 30, 2021 | 6,692.00 |
| Mar 31, 2021 | 7,135.00 |
| Dec 31, 2020 | 7,372.00 |
| Sep 30, 2020 | 5,109.00 |
| Jun 30, 2020 | 2,513.00 |
| Mar 31, 2020 | 6,354.00 |
| Dec 31, 2019 | 4,461.00 |
| Sep 30, 2019 | 4,029.00 |
| Jun 30, 2019 | 11,991.00 |
| Mar 31, 2019 | 12,518.00 |
| Dec 31, 2018 | 1,128.00 |